PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Phase 1 Dose Escalation Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors

Phase 1 Dose Escalation Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors


Basic Trial Information

Protocol Phase:Phase I
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary IDARQ 087-101
Other IDNCT01752920
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: